Press Releases

Artizan Biosciences Announces Corporate Progress and Financing

June 10, 2019

Finalized Series A funding, bringing total raised to date to $12MM to support proprietary platform that enables identification of disease-driving bacteria and development of therapies for inflammatory diseases. Appointed Paul Miller, PhD, as Chief Scientific Officer. Moved to specialized microbiology facility in New Haven’s Science Park.

Read Full Release ❯

❮ Back to Press Releases